These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population. Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C. Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423 [Abstract] [Full Text] [Related]
3. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Tripodi A, Chantarangkul V, Clerici M, Mannucci PM. Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227 [Abstract] [Full Text] [Related]
5. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India. Ahluwalia J, Sreedharanunni S, Kumar N, Masih J, Bose SK, Varma N, Varma S, Singh S. Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011 [Abstract] [Full Text] [Related]
6. [Usefulness of silica clotting time for detection of lupus anticoagulants]. Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI. Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079 [Abstract] [Full Text] [Related]
7. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems. Hong SK, Hwang SM, Kim JE, Kim HK. Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767 [Abstract] [Full Text] [Related]
12. Lupus anticoagulant diagnosis in activated partial thromboplastin time mixing test: optimization of the index of circulating anticoagulant cut-off value. Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N, Suzuki T, Aoki T. Clin Lab; 2014 Dec; 60(12):2115-8. PubMed ID: 25651752 [No Abstract] [Full Text] [Related]
15. Screening for lupus anticoagulants in patients treated with vitamin K antagonists. Isert M, Miesbach W, Stoever G, Lindhoff-Last E, Linnemann B. Int J Lab Hematol; 2015 Dec 26; 37(6):758-65. PubMed ID: 26224222 [Abstract] [Full Text] [Related]
16. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients. Moore GW, Platton S, Yartey N, Foxton E, White D, MacDonald SG. Int J Lab Hematol; 2024 Jun 26; 46(3):538-545. PubMed ID: 38303489 [Abstract] [Full Text] [Related]
17. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome. Arachchillage DR, Mackie IJ, Efthymiou M, Isenberg DA, Machin SJ, Cohen H. J Thromb Haemost; 2015 Jul 26; 13(7):1264-73. PubMed ID: 25850997 [Abstract] [Full Text] [Related]
18. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr 26; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related]
19. Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects. Amiral J, Peyrafitte M, Dunois C, Vissac AM, Seghatchian J. Transfus Apher Sci; 2017 Aug 26; 56(4):612-625. PubMed ID: 28803708 [Abstract] [Full Text] [Related]
20. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. Swadzba J, Iwaniec T, Pulka M, De Laat B, De Groot PG, Musial J. J Thromb Haemost; 2011 Sep 26; 9(9):1776-83. PubMed ID: 21707912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]